5.1. Antioxidant Activities
GLP possess a multitude of bioactive properties, with their antioxidant activity being one of the most reported. GLP exhibit robust antioxidant activities through several well-documented mechanisms, primarily by scavenging free radicals—unstable molecules that cause significant cellular damage through oxidative stress [
75,
76]. The biological activities, related mechanisms of action, and structural information of GLP are summarized in
Table 1. Reactive oxygen species (ROS), including superoxide anions, hydroxyl radicals, and hydrogen peroxide, as well as reactive nitrogen species such as nitric oxide and peroxynitrite, pivotal in the onset and progression of various diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions [
77,
78]. GLP can donate hydrogen atoms or electrons to these reactive species, neutralizing them and mitigating their harmful effects. Wang et al. demonstrated the radical scavenging activities of GLP in vitro using assays such as the superoxide radical assay, hydroxyl radical assay, DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging assay, and reducing power assay. [
79]. In another study, the scavenging ability of GLP showed an IC
50 of 9.62 mg/mL for ABTS (2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)) radicals, 23.85 mg/mL for DPPH, 4.97 mg/mL for ferric ion, and 3.56 mg/mL for superoxide radicals [
80]. Additionally, in cell culture studies on human keratinocyte cells (HaCaT) exposed to H
2O
2, a common inducer of oxidative stress, GLP significantly reduced ROS levels and increased the expression of Nrf-2/Keap-1, a key transcription factor regulating antioxidant responses [
80]. This radical scavenging capability of GLP is crucial for maintaining cellular homeostasis and preventing oxidative damage to tissue and organ proteins, lipids, and nucleic acids.
In addition to directly neutralizing free radicals, GLP enhance the body’s antioxidant defense systems by upregulating the activity of endogenous antioxidant enzymes, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). SOD catalyzes the dismutation of superoxide radicals into oxygen and hydrogen peroxide, which CAT then breaks down into water and oxygen. GPx further reduces hydrogen peroxide to water, using glutathione as a substrate. By increasing the levels and activity of these enzymes, GLP bolster the cellular antioxidant defense mechanism, enhancing the overall capacity to detoxify harmful ROS. Fang et al. investigated the antioxidant activity of GLP in in vitro cell culture assays and reported that GLP alleviated H
2O
2-induced oxidative injury in human fetal lung fibroblast 1 cells by protecting them from oxidative damage and increasing the activities of SOD, CAT, and GPx [
81].
Aging and diabetes are strongly connected to oxidative stress, which occurs when there is a disparity between the production of ROS and the body’s ability to counteract them with antioxidant defenses [
82,
83]. Antioxidant enzyme activity typically declines with age and chronic hyperglycemia, exacerbating oxidative damage [
84]. In vivo studies indicate that GLP can mitigate oxidative stress related to both aging and diabetes. Zhang et al. found that GLP markedly restored the levels of antioxidant enzymes—SOD, CAT, and GSH-Px—in the serum and brain of D-galactose-induced aging mice, in a dose-dependent manner [
85]. Similarly, in streptozotocin-induced diabetic mice, GLP treatment significantly increased the levels of SOD, GSH-Px, and CAT [
86]. In addition, ultraviolet (UV) radiation in the environment can induce oxidative stress in living organisms. UV radiation, particularly UVA (320-400 nm) and UVB (280-320 nm) wavelengths, penetrates the skin and interacts with cellular components, generating ROS. In an in vitro assay, UVB-induced damage decreased intracellular levels of GSH and SOD in HaCaT cells, while GLP treatment increased these levels, demonstrating that GLP protected the cells from UVB-induced damage [
87].
5.2. Immuno-Modulatory Activity
The immune system is essential for overall health and well-being, serving as the body’s primary defense against pathogens and disease [
88]. It consists of a complex network of cells, tissues, and organs that work together to detect and neutralize harmful invaders such as bacteria, viruses, fungi, and parasites [
89]. GLP have demonstrated significant immunomodulatory activities by activating macrophages. These cells are vital to the innate immune system, as they detect, engulf, and destroy pathogens and apoptotic cells, thereby enhancing the body’s immune responses [
90]. Ren et al. reported that treatment with GLP has been shown to increase the phagocytic capability of RAW264.7 cells and increase the production of nitric oxide and ROS. Additionally, GLP stimulate the secretion of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), further amplifying the immune response [
57]. Proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6) are produced by immune cells, including macrophages, dendritic cells, and T-lymphocytes, in response to pathogens or cellular damage [
91,
92]. These cytokines are crucial mediators of the immune response, promoting inflammation to defend against infections and injuries. However, the overproduction or prolonged presence of proinflammatory cytokines can lead to chronic inflammation, contributing to the progression of various inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and cardiovascular diseases [
93,
94]. Thus, maintaining a balanced cytokine response is critical for effective immune defense while preventing the detrimental effects of chronic inflammation. In a lipopolysaccharide-induced IEC-6 cell model, GLP co-culture with IEC-6 cells decreased the release and inhibited the gene expression of TNF-α, IL-6, and IL-1β, demonstrating significant anti-inflammatory effects [
42,
95].
Another mechanism of GLP’s immunomodulatory effect involves modulating lymphocyte proliferation and differentiation. Lymphocytes, including T cells and B cells, play pivotal roles in adaptive immunity [
96]. In individuals with food allergies, the immune system mistakenly identifies harmless food proteins as threats [
97], triggering the activation of T-helper 2 (Th2) cells. These cells release cytokines such as IL-4 and IL-13. Liu et al. investigated GLP’s potential to alleviate food allergies using tropomyosin-sensitized mice. They found that GLP significantly reduced Th2-dependent tropomyosin-specific IgE and IgG1 serum levels and decreased the production of IL-4 and IL-13. The immunosuppressive mechanism may be related to a reduction in p38 MAPK activity, contributing to the mitigation of food allergy symptoms [
11,
98,
99]. The oligosaccharide derived from GLP has been demonstrated to modulate type 1 immunity by suppressing T cell activation, as evidenced by studies conducted both in vivo and
in vitro.
In vivo, this oligosaccharide reduced the production of interferon-gamma (IFN-γ) in mice immunized with ovalbumin.
In vitro, using OT-II CD4
+ T cells, the oligosaccharide inhibited mTOR activity, glycolysis, cell cycle progression, and DNA replication [
100].
5.3. Anti-Tumor Activity
The significance of polysaccharides derived from natural resources in cancer research is notably accentuated by their low or non-toxicity, distinguishing them from many conventional chemotherapeutic agents [
101,
102]. GLP exhibit anti-tumor activity primarily through significant immune modulation. They enhance immune cell activity by stimulating the proliferation and activation of immune cells such as T lymphocytes, natural killer cells, macrophages, and [
103]. Ji et al. investigated the antitumor effects of GLP on Kunming mice transplanted with S180 tumor cells in the armpit of the right hind limbs. They found that GLP suppressed the aggressive growth of solid S180 tumors by enhancing the proliferation of splenocytes, increasing the cytotoxic activity of natural killer cells, and elevating the serum cytokine levels of IL-2, IFN-γ, and TNF-α [
104]. This cytokine modulation not only boosts overall immune surveillance and attack on tumor cells but also helps reduce the immunosuppressive environment often created by tumors [
105].
Moreover, GLP exhibit antitumor activity through the direct inhibition of tumor growth. Kang et al. reported that GLP showed inhibitory effects on the growth of three cancer cell lines: human gastric cancer cell line MKN45, cervical carcinoma cell line HeLa, and non-small cell lung cancer cell line A549, and. Their transcriptome analysis demonstrated that GLP regulated apoptosis, the cell cycle, nuclear division, and cell death-related genes [
106]. Shi et al. also reported similar findings, demonstrating that GLP inhibit the proliferation of various cancer cell lines
in vitro. These include human breast cancer cells MCF-7, HeLa, and human hepatocellular carcinoma cells HepG2 [
29]. Another study demonstrated that GLP inhibit the proliferation of various cancer cell lines, including gastric cancer cell line MKN28, human lung cancer cell line A549, and mouse melanoma cell line B16. This suppression is associated with increased expression of the Fas/FasL signaling pathway [
61]. Fas (CD95) is a death receptor located on the cell surface, and its ligand, FasL, binds to it, triggering a cascade of events that lead to programmed cell death [
107]. GLP enhance the expression of both Fas and FasL or increase their interaction. This activation of the Fas/FasL pathway promotes the formation of the death-inducing signaling complex, which further facilitates apoptosis. Cai et al. demonstrated that GLP effectively inhibits tumor growth in a mouse model bearing colon-26 carcinoma. This anti-tumor effect is primarily mediated through the induction of ferroptosis and the regulation of ferroptosis-related metabolic pathways [
108]. Ferroptosis is a type of programmed cell death characterized by the accumulation of lipid peroxides and the depletion of intracellular glutathione, is crucial for the antitumor activity of investigated samples [
109]. The study found that GLP promotes ferroptosis by inhibiting glutathione synthesis and disrupting the function of glutathione peroxidase 4, an enzyme essential for protecting cells from lipid peroxidation. Additionally, GLP increases the levels of 4-hydroxy-2-nonenal, a marker of lipid peroxidation, further driving ferroptosis. This mechanism highlights the potential of GLP as a therapeutic agent that leverages ferroptosis to enhance its efficacy in targeting cancer cells, offering a promising approach for cancer treatment [
108].
5.4. Intestinal Health and Gut Microbiota
The gut microbiota is a diverse population of microorganisms residing in the gastrointestinal tract, and it is essential for maintaining intestinal health and overall well-being [
110]. A healthy gut ensures efficient digestion and nutrient absorption, supports a robust immune system, and maintains the integrity of the gut barrier, preventing harmful pathogens and toxins from entering the bloodstream [
111,
112]. Disruptions in gut health can lead to various diseases. Conditions like inflammatory bowel disease (IBD), which encompasses ulcerative colitis and Crohn’s disease, involve chronic inflammation of the gut lining, causing severe abdominal pain, diarrhea, and malnutrition [
113,
114]. Furthermore, gut dysbiosis has been linked to metabolic diseases such as obesity, type 2 diabetes, heart disorders, and non-alcoholic fatty liver disease [
115,
116,
117]. Beyond intestinal and metabolic health, the gut microbiota also significantly influences mental health through the gut-brain axis, a bidirectional communication network connecting the central nervous system and the gastrointestinal tract [
118]. Therefore, maintaining a balanced gut microbiota is essential for promoting intestinal health and preventing disease [
119].
Prebiotics are non-digestible food components that positively impact the host by promoting the growth or activity of specific beneficial microorganisms in the colon [
120,
121]. GLP can serve as prebiotics because they remain undigested in the upper gastrointestinal tract. [
122]. Studies have shown that GLP resists digestion by simulated gastric conditions, including exposure to gastric juice containing pepsin, gastric lipase, and HCl at pH 3.0. Additionally, GLP is not digested by amylase or by components of intestinal juice such as pancreatin, trypsin, and bile salts [
17]. These findings indicate that GLP remains intact in the upper gastrointestinal tract and may reach the large intestine, where it can be fermented and utilized by gut microbiota [
123].
The intestinal flora consists of a diverse community of microorganisms, predominantly from four phyla: Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria [
124]. GLP can be fermented by Bacteroidetes. An in vitro simulated human fecal fermentation assay showed that GLP increased Bacteroidetes’ relative abundance while decreasing that of Firmicutes [
10]. Bacteroidetes utilize various carbohydrate-active enzymes (CAZymes) to break down complex polysaccharides. These include glycoside hydrolases, which cleave glycosidic bonds in polysaccharide chains [
125]. CAZymes are categorized by their specific functions and substrate preferences, allowing Bacteroidetes to degrade a wide range of polysaccharides such as xylans, glucan, mannan, arabinans, and agarans [
63,
126]. It has been established that Bacteroides plebeius possesses an endo-type β-agarase, BpGH16A, which is part of the glycoside hydrolase (GH) family 16. This enzyme breaks β-1,4-glycosidic bonds in agarose, generating neoagarooligosaccharides. [
127]. Co-culturing red seaweed polysaccharides with
Bacteroides thetaiotaomicron revealed the presence of a GH16 family enzyme that catalyzes the hydrolysis of β-D-galactopyranose-(1→4)-α-L-galactopyranose-β-6-sulfate linkages [
128]. Additionally, the bacterium
Aquimarina sp. AD1, which belongs to the Bacteroidetes phylum, contains GH96 family enzymes with specific activity targeting the α-1,3 linkage in LAα1 → 3G6S of funoran [
129]. Bacteroidetes engage in a synergistic approach to break down complex polysaccharides. For instance,
Bifidobacteria and
Lactobacillus further process oligosaccharides that Bacteroidetes initially degrade. This interspecies cooperation involves exchanging intermediate metabolites, enhancing the breakdown of dietary fibers and improving the efficiency of carbohydrate fermentation. This is why GLP can increase the relative abundance of both
Bacteroidetes spp. and
Bifidobacteria spp., while reducing the relative abundance of
Escherichia [
10].
The gut microbiota breaks down GLP into smaller carbohydrates and monosaccharides, leading to the production of short-chain fatty acids (SCFAs) [
130,
131]. The main SCFAs are acetate, propionate, and butyrate, each contributing uniquely to gut health and overall physiological functions [
132]. Acetate, the most prevalent SCFAs, is used by peripheral tissues for energy and helps regulate cholesterol levels [
133]. Propionate, though less abundant, aids in glucose regulation and is linked to a lower risk of metabolic disorders such as obesity and type 2 diabetes [
134]. Butyrate is vital for colon health, serving as the primary energy source for colonocytes, enhancing gut barrier integrity through mucus production and tight junction formation, and providing anti-inflammatory benefits [
135,
136]. SCFAs exert their physiological effects through specific receptors on the surface of various cell types in the gut and other tissues. The primary SCFAs receptors are G-protein coupled receptors (GPCRs), namely GPR41 (also known as free fatty acid receptor 3, FFAR3), GPR43 (FFAR2), and GPR109A [
137,
138]. Research by Han et al. demonstrated that GLP alleviated DSS-induced colitis in mice. The study found that increased expression of SCFAs receptors, such as GPR43, GPR109A, and the olfactory receptor Olfr78, along with elevated SCFAs levels in feces, indicated substantial SCFAs absorption in the colon. This upregulation significantly enhanced the integrity of intestinal tight junctions, including zonula occludens-1, claudin-1, and mucin, thereby strengthening the intestinal barrier. Furthermore, the beneficial effects of SCFAs on the intestinal barrier may be linked to the presence of bacteria such as
Enterorhabdus,
Desulfovibrio,
Alistipes, and
Bacteroides acidifaciens [
139]. SCFAs are also vital in regulating the immune response, maintaining immune tolerance, and preventing excessive inflammation [
140,
141]. GLP can alleviate DSS-induced colitis by increasing SCFAs levels. Additionally, GLP treatment resulted in decreased levels of CC chemokine ligand-25 (CCL-25) and CC-chemokine receptor-9 (CCR-9), while CD40 and TGF-β1 levels were elevated [
142]. CCR-9, the receptor for CCL-25, is primarily expressed on T cells that migrate to the gut. By inhibiting CCL-25 and CCR-9, GLP reduces the infiltration of inflammatory T cells into the gut, thereby mitigating intestinal inflammation [
143,
144]. CD40, a co-stimulatory protein on antigen-presenting cells, interacts with CD40 ligand on T cells to activate and proliferate both T cells and B cells, thus enhancing adaptive immunity [
145].